$MITD - MIT Holding Inc. MITD Company Description Through

New Post Public Reply Private Reply Replies (1) Message Board
PYCKtradr
$MITD - MIT Holding Inc.



MITD Company Description
Through its wholly owned subsidiaries, MIT Holding Inc. distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, consults and operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil. MIT's domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.

MITD’s other subsidiaries include LowCountry Compounding Pharmacy and ProVector.

MITD has invested $1M in capital improvements into LowCountry Compounding Pharmacy. With the introduction of robotics, this division now has the growth capabilities to handle in excess of $100M of gross annual sales of pharmaceuticals.

The ProVector® Entobac® Patent Pending was developed by Dr. Tom Kollars at MEVLABS, Inc. to be an economical and environmentally safe “GREEN” device for killing adult mosquitoes. The ProVector Entobac is the first device capable of killing adult mosquitios with Bt biopesticide; which is virtually non-toxic according to the EPA.

One of MITD subsidiaries many products ProVector Entobac was even featured on CNN as a breakthrough Green pesticide. See it here: http://vimeo.com/42477892

MITD Products and Services


MITD distributes wholesale pharmaceuticals in the US and overseas, administers intravenous infusions and, in Georgia, consults and operates ambulatory centers where therapies are administered and sells and rents home medical equipment.

MITD has initiated government contracts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil.

MITD’s domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.

The Company plans to commence rapid growth through a series of acquisitions for each of its divisions. Management is in active negotiations for a number of acquisitions that will grow the Company by adding both products and services that will benefit clients worldwide.


Medical Infusion Technologies
When you or a loved one has been discharged from the hospital or has received special instructions from a physician for continued outpatient care, ask your healthcare provider to refer you to Medical Infusion Technologies. We specialize in offering professional, caring Ambulatory Infusion Therapy, Home Infusion Therapy, Medical Equipment services – including walkers, wheelchairs and respiratory equipment – and much more to residents in Southeast Georgia and the South Carolina Low Country. Medical Infusion Technologies even offers 24/7 on-call nursing, personalized training on select services and equipment and we handle all of your insurance paperwork. When you’re in need of our expert care, choose Medical Infusion Technologies. Ask your healthcare provider to refer you today.

CLICK HERE TO VISIT THE MEDICAL INFUSION TECHNOLOGIES WEB SITE http://medicalinfusion.com/
http://www.mitholdingsinc.com/divisions/medic...chnologies

MITD Key Company Management
William C. Parker, Co-President and Co-Chairman of the Board of Directors
Mr. Parker has served as President, Co-President and Co-Chairman of the Board of Directors of MIT Holding Inc. since its inception in 2006. Mr. Parker has managed MIT since founding the business in 1990. He currently serves as President, Chief Executive Officer and member of the board of directors of MIT Holding Inc.'s two operating subsidiaries. Mr. Parker attended Armstrong State University in Savannah, Georgia and graduated from the American Banking Institute in Savannah Georgia.

Walter H.C. Drakeford, Co-President and Co-Chairman of the Board of Directors
Mr. Drakeford joined MIT Holding, Inc. in 2010 as Co-President and Co-chairman of the Board of Directors. His stellar career includes being the senior managing director of Drakeford & Drakeford for the past 20 years. Since 2007, he has been the director of mergers and acquisitions of AMC Global Communications, Inc. Mr. Drakeford served as chairman of the board for Ebank Financial Services. He has also served on the boards of Netstar-USA Corp. and LaidLaw Transportation as well as serving as an attaché to the White House under Presidents Nixon, Reagan and George H.W. Bush. Mr. Drakeford holds a finance degree from the University of Berlin and a Masters of Business Administration from Heed University. He also holds a law degree from Thomas Jefferson School of Law.

http://www.mitholdingsinc.com/company-overvie...reInfo-270

MITD Contact Info
MIT Holding Inc.
351B Commercial Way
Savannah, GA 31406

Website: http://www.mitholdingsinc.com/home-2
Phone: (912) 925-1905

MITD SEC Filings
http://www.otcmarkets.com/stock/MITD/filings

MITD Headlines
http://finance.yahoo.com/q?s=MITD&x=53&y=16

Investigate more about MITD @ http://www.otcmarkets.com/stock/MITD/quote for more due diligence.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 295

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 112

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 98

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 176

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Long-Term Value Growth of Digital Realty Trust

Updated Category News Views 203

Digital Realty Trust: A 20-Year Journey of Growth Digital Realty Trust (NYSE: DLR) stands as a beacon of successful investing over the past two decades, consistently yielding remarkable returns. Rolling forward from the turn of the millennium to the current day, an investment made in this data center REIT has not just maintained its value but has outperformed traditional...

Continue Reading
Robotic Innovations Drive Future of Inspection and Maintenance Market

Updated Category News Views 187

Inspection and Maintenance Robots Market Overview The Inspection and Maintenance Robots Market is set to witness significant growth as industries embrace automation for improved efficiency and safety. According to market analysts, the size was valued at USD 41.66 billion in 2023 and is expected to soar to USD 146.9 billion by 2032, translating to a compound annual growth...

Continue Reading
Exploring the Growth of the Sports Analytics Market

Updated Category News Views 266

Understanding the Sports Analytics Market The Sports Analytics Market is experiencing notable expansion, primarily fueled by the rising demand for AI-driven analytics, the need for real-time performance insights, and enhanced strategies for player and team management. Despite its growth, challenges such as high implementation costs and data integration difficulties may...

Continue Reading
Exploring the Launch of Lit Protocol's Innovative AI Stack

Updated Category News Views 177

Revolutionizing AI with Lit Protocol's Decentralized Agent Stack Lit Protocol is inviting developers to harness the power of a decentralized AI agent stack that facilitates on-chain agents capable of autonomous transactions. This toolkit provides developers the ability to create these innovative agents, complete with wallet keys, enabling them to transact independently...

Continue Reading
Exploring the Promise of SKB264 in Cancer Treatments

Updated Category News Views 140

Introducing SKB264: A Major Breakthrough in Cancer Treatment SKB264, also referred to as MK-2870, signifies a significant leap in cancer therapy. This advanced antibody-drug conjugate (ADC) specifically targets TROP2 and is being developed through a collaboration between Kelun Biotech and MSD. Utilizing the state-of-the-art OptiDC platform, this therapy incorporates a...

Continue Reading